非小细胞肺癌EML4-ALK融合基因检测的临床意义
被引量:1
摘要
近年来,靶向药物治疗成为肺癌治疗热点,越来越多的分子靶点的发现及靶向药物的研发给肺癌患者长期生存带来希望。
出处
《中华检验医学杂志》
CAS
CSCD
北大核心
2012年第9期862-864,共3页
Chinese Journal of Laboratory Medicine
基金
国家高技术研究发展计划(863计划)资助项目(2011AA02A110)
国家重大新药创制科技重大专项资助项目(2012ZX09303012)
卫生部卫生公益性行业科研专项资助项目(200902002-1)
中央保健资助课题(B2009B124)
参考文献16
-
1Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EMIA-ALK fusion gene in non-small-cell lung cancer. Nature, 2007,448:561-566.
-
2Morris SW, Nacre C, Mathew P, et al. ALK, the chromosome 2 gene locus altered by the t (2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kiuase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene, 1997,14 : 2175-2188.
-
3Koivunen JP, Mermel C, Zejnullahn K, et al. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin Cancer Res, 2008,14:4275-4283.
-
4杨统,刘红雨,陈军.肺癌中EML4-ALK融合基因的存在状态及生物学功能[J].中国肺癌杂志,2012,15(2):112-116. 被引量:2
-
5Inamura K, Takeuchi K, Togashi Y, et al. EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers. J Thorac Oncol, 2008,3 : 13-17.
-
6Koivunen JP, Mermel C, Zejnullahu K, et al. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin Cancer Res, 2008,14:4275-4283.
-
7Inamura K, Takeuchi K, Togashi Y, et al. EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage,an acinar histology,and young onset. Mod Pathol, 2009, 22:508-515.
-
8Martelli MP, Sozzi G, Hemandez L, et al. EML4-ALKRearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues. American J Pathol, 2009 ; 174:661-670.
-
9Shaw AT, Yeap BY, Mino-Kenudson M, et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EMIA-ALK. J Clin Oncol, 2009,27:4247-4253.
-
10Wang DW, Leung EL, Kam-Ting K, et al. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from non-smokers with wild-type EGFR and KRAS. Cancer, 2009, 115:1723-1733.
二级参考文献26
-
1Mitsudomi T,Morita S,Yatabe Y,et al.Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor(WJTOG3405):an open label, randomised phase 3 trial.Lancet Oncol,2010,11(2):121-128.
-
2Horn L,Pao W.EML4-ALK:honing in on a new target in non-small-cell lung cancer.J Clin Oncol,2009,27(26):4232-4235.
-
3Jokoji R,Yamasaki T,Minami S,et al.Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma.J Clin Pathol,2010,63(12):1066-1070.
-
4Sabbatini P,Korenchuk S,Rowand JL,et al.GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers.Mol Cancer Ther,2009,8(10):2811-2820.
-
5Shaw AT,Yeap BY,Mino-Kenudson M,et al.Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK J Clin Oncol,2009,27(26):4247-4253.
-
6Lin E,Li L,Guan Y,et al.Exon array profiling detects EML4-ALK fusion in breast,colorectal,and non-small cell lung cancers.Mol Cancer Res,2009, 7(9):1466-1476.
-
7Anastasov N,Bonzheim I,Rudelius M,et al.C/EBPbeta expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway.Haematologica,2010,95(5): 760-767.
-
8Singh RR,Cho-Vega JH,Davuluri Y,et al.Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma.Cancer Res,2009,69(6):2550-2558.
-
9Perner S,Wagner PL,Demichelis F,et al.EML4-ALK fusion lung cancer:a rare acquired event.Neoplasia,2008,10(3):298-302.
-
10Zhang X,Zhang S,Yang X,et al.Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression.Mol Cancer,2010,9:188.
同被引文献26
-
1田宁,张侠,高文斌,等.非小细胞肺癌组织中EML4.ALK融合基因与ERCCl和RRMlmRNA表达的关系[J/CD].中华临床医师杂志:电子版,2013,7(22):9988-9922.
-
2Shaw AT, Yeap BY, Solomon BJ, et a|. Effect of crizotinib on overall survival in patients with advanced non-small cell lungcancer harbouring ALK gene rearrangement: a retrospective analysis[J]. Lancet Oncol, 2011, 12( 11 ) : 1004 -1012.
-
3MeLeer-Florin A, Moro-Sibilot D, Melis A, et al. Dual IHC and FISH testing for ALK gene rearrangement in lung adenocarc- inomas in a routine practic, e: a French study[J]. J Thorac Oncol, 2012, 7(2): 348-354.
-
4Lin E, Li L, Guan Y, el al. Exon array profiling detects EM IA -ALK fusion in breast, coloreetal, and non-small cell lung cancers [J]. Mol Cancer Res, 2009, 7(9): 1446-1447.
-
5李东吉,李秀营.晚期肺癌治疗新药——Xalkori[J].齐鲁药事,2011,30(11):681-682. 被引量:3
-
6何文武,冼磊.非小细胞肺癌EML4-ALK融合基因1型的表达研究[J].广西医科大学学报,2011,28(5):692-695. 被引量:2
-
7林小梅,莫娟梅,邹敏,曾爱屏,于起涛,周韶璋,宋向群.EGFR突变的非小细胞肺癌患者EML4-ALK融合基因的检测及其临床特征分析[J].中国病理生理杂志,2012,28(6):1135-1139. 被引量:20
-
8钟山,张海萍,郑捷,白冬雨,付莉,陈培琼.非小细胞肺癌患者EML4-ALK融合基因检测及其与临床病理特征的关系[J].中华病理学杂志,2013,42(4):252-256. 被引量:19
-
9吴霞,李代强.ALK和EGFR蛋白在非小细胞肺癌中的表达及意义[J].国际病理科学与临床杂志,2013,33(2):120-123. 被引量:7
-
10金涛,朱理,赵琼,方维嘉,曾蕾,彭玲,王一青.检测EML4-ALK融合基因对肺腺癌患者的临床意义[J].浙江医学,2013,35(9):737-740. 被引量:1
-
1王全林,杨广恺.CIP2A、c-Myc蛋白在食管鳞状细胞癌中的表达及其临床意义[J].医药论坛杂志,2011,32(24):30-32. 被引量:3
-
2王海燕,闫磊,兰文军.非小细胞肺癌驱动基因检测研究进展[J].齐鲁工业大学学报,2014,28(3):60-64.
-
3许佳丽,束永前.EML4-ALK在非小细胞肺癌中的研究进展[J].癌症进展,2011,9(5):528-532. 被引量:2
-
4袁彩萍,李小俊,韩晓兵,史博,朱克修.S100A4蛋白在宫颈癌中的表达和意义[J].中国妇幼健康研究,2010,21(4):444-447. 被引量:2
-
5乐萍,段荣,张小珍.急性淋巴细胞白血病常见融合基因检测及临床研究进展[J].国际检验医学杂志,2011,32(21):2484-2487. 被引量:5
-
6黄金宁,石毅然,张居民,曲建军,林明臻.BRCA1,EGFR,CK5/6在三阴乳腺癌中的表达及其临床意义[J].潍坊医学院学报,2011,33(1):4-6. 被引量:1
-
7黎扬斯,吴一龙.肺癌的新治疗靶点[J].循证医学,2016,16(5):314-316.
-
8陈涛,谢黎明,周秀田.胃癌组织中CD_(147)和整合素α3的表达变化及意义[J].山东医药,2013,53(27):33-34. 被引量:6
-
9杨自国,郭晓波,石玉龙,李辰生,李乐平.MSI2在胃癌中的表达及其意义[J].中国普外基础与临床杂志,2016,23(1):52-55. 被引量:2
-
10赵军.肺癌靶向治疗进展[J].临床外科杂志,2016,24(7):514-517. 被引量:10